Clinical reference Biomarker Directory
Back to directory

LTF

Established

Fecal lactoferrin is a noninvasive inflammation marker that helps distinguish IBD from irritable bowel syndrome.

Also known as Lactoferrin fecal lactoferrin
In plain language

Lactoferrin is a protein that rises in stool when there's gut inflammation. Testing for it helps tell apart inflammatory bowel disease from irritable bowel syndrome, which looks similar based on symptoms alone but doesn't cause the same inflammation.

Biomarker & context

Lactoferrin is an iron-binding antimicrobial protein secreted by neutrophils and mucosal glands; fecal lactoferrin is used as a noninvasive marker of intestinal inflammation.

What it indicates

Elevated fecal lactoferrin helps distinguish inflammatory bowel disease (Crohn's disease, ulcerative colitis) from irritable bowel syndrome, which doesn't cause the same inflammatory marker elevation, avoiding unnecessary invasive testing in some patients.

Diagnosis & clinical testing

Measured via stool immunoassay, often alongside fecal calprotectin (a related inflammatory marker); both tests serve a similar noninvasive screening role before proceeding to colonoscopy.

Guiding treatment

A negative fecal lactoferrin in a patient with IBS-type symptoms supports a functional (non-inflammatory) diagnosis without requiring colonoscopy, while a positive result prompts endoscopic evaluation for IBD.

Clinical significance

Often used alongside fecal calprotectin for a similar noninvasive screening purpose before colonoscopy.

References
  1. General gastroenterology reference literature on fecal lactoferrin and calprotectin in distinguishing IBD from IBS.